Events

Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 February 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

European Medicines Agency, Amsterdam, the Netherlands
Start date: 5 February 2024
End date: 8 February 2024
EventHumanPharmacovigilance
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system

EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...

Online
Start date: 29 January 2024
End date: 2 February 2024
Event
Committee for Medicinal Products for Human Use (CHMP): 22-25 January 2024

The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.

European Medicines Agency, Amsterdam, the Netherlands
Start date: 22 January 2024
End date: 25 January 2024
EventHumanMedicines